4//SEC Filing
HALAS GUS D 4
Accession 0001628280-22-025810
CIK 0001448431other
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:44 PM ET
Size
10.1 KB
Accession
0001628280-22-025810
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
HALAS GUS D
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-09-29+334→ 0 total→ Common Stock (334 underlying) - Exercise/Conversion
Common Stock
2022-09-29+334→ 65,162 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On September 29, 2021 the reporting person was granted 334 restricted stock units which vested in full on September 29, 2022.
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001230322
Filing Metadata
- Form type
- 4
- Filed
- Sep 29, 8:00 PM ET
- Accepted
- Sep 30, 4:44 PM ET
- Size
- 10.1 KB